Henry Schein sets next earnings date, NASDAQ shares near recent highs

Henry Schein has scheduled its next quarterly update for early August, while the NASDAQ-listed shares trade close to recent highs on the back of steady consensus expectations.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-25, 18:24.

Henry Schein (US8064071025) is approaching its next quarterly earnings window. The NASDAQ-listed health care distributor carries a scheduled earnings date of August 6, 2026, according to recent consensus data.

What analysts expect

Henry Schein is followed by a broad set of US sell-side houses, with MarketBeat showing upcoming earnings on August 6, 2026 for the HSIC ticker and a current share price of 82.82 dollars as of June 24, 2026 close. The MarketBeat earnings overview lists Wall Street estimates for revenue and EPS around this date.

Consensus data compiled by financialdata.net point to a recent spot price of 83.93 dollars on June 25, 2026 at 10:49 Eastern for Henry Schein, reflecting a 1.3 percent gain on the day and situating the shares close to recent highs. The HSIC quote page on financialdata.net also identifies the company as the world’s largest provider of health care solutions to office-based dental and medical practitioners.

The earnings timetable

For the upcoming August report, Henry Schein is expected to present second-quarter 2026 figures after a prior update in early May, when it last reported quarterly numbers on NASDAQ. MarketBeat’s earnings calendar lists the August 6, 2026 date as the next formal call, giving investors a clear timetable for updated guidance and margin commentary.

Historically, Henry Schein has provided detailed segment breakdowns in its earnings releases, covering dental, medical and technology solutions. The August call is likely to address demand trends in US and international markets, with attention on procedure volumes and practice investments in equipment and digital tools, as indicated by previous transcripts referenced on analyst platforms. Earlier call transcripts hosted on MarketBeat provide context on management’s tone and strategic priorities.

The business behind the stock

Henry Schein generates its revenues primarily by distributing dental supplies, medical consumables, vaccines, pharmaceuticals and practice management software to office-based practitioners worldwide. The company’s catalog includes core dental products such as restorative materials, instruments and hygiene items, alongside digital solutions like practice management systems and imaging equipment tailored to small and mid-sized practices.

Where the stock trades today

The Henry Schein shares (US8064071025) trade on NASDAQ at 83.93 dollars as of 2026-06-25, 10:49 Eastern, based on financialdata.net figures.

Key data on the Henry Schein shares

• Company: Henry Schein, Inc.
• ISIN: US8064071025
• WKN: 881793
• Ticker: HSIC
• Trading venue: NASDAQ
• Price (as of 2026-06-25, 10:49): 83.93 USD
• Market cap: approximately 11.5 billion USD (as of 2026-06-25)
• Sector / industry: Health Care Equipment & Distribution
• Index membership: S&P 500
• Next earnings date: 2026-08-06

Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or any other form of financial guidance. All data are based on sources believed to be reliable but may be subject to change.